Forbius is a clinical stage company that designs and develops biotherapeutics for treatment of cancer and fibrosis. The company was acquired by Bristol Myers Squibb in August 2020.
Forbius is a clinical stage company that designs and develops biotherapeutics for treatment of cancer and fibrosis. The company was acquired by Bristol Myers Squibb in August 2020.